ITCC is an academic network bringing together all the
required knowledge and know-how for the development of new treatments for
children with cancer. With over 55 trials run in its extensive network of
62 clinical trial centers, ITCC has a proven track record of over 20 years
of bringing treatment innovation to patients.
What can ITCC do for you?
ITCC is an open and highly collaborative network of researchers and hospitals with extensive experience in paediatric oncology. The network frequently partners with international disease specific treatment groups, academic trial sponsors, researchers and both small and large pharma to cooperatively strive towards developing new trial ideas into feasible early phase clinical trials. With a clinical trial sponsors committee as well as focused solid tumor, hematology and brain tumor scientific committees, ITCC offers expertise across the board covering all aspects of paediatric oncology drug development. Since 2021 to date, ITCC has evaluated over 35 trial proposals advising on all aspects ranging from molecular mechanism of action, treatment strategy, target population and organizational aspects to optimize the recruitment strategy.
ITCC investigators, if you have an early phase trial idea or are considering developing one, do not hesitate to get in touch with ITCC at the earliest opportunity!
ITCC Publication Track Records
As an academic network, ITCC has contributed to an extensive number of publications on pediatric oncology drug development, trial results and organizational aspects of trial conduct. In this page you can find the non-trial specific publications. The trial related papers will be available soon in the ITCC Clinical Trials Portfolio.
